Apolipoprotein E and its receptors in Alzheimer’s disease: pathways, pathogenesis and therapy
Aβ accumulation in the brain parenchyma leads to formation of Aβ oligomers and amyloid plaques, which are toxic to neurons, whereas its accumulation in the perivascular region leads to the formation of CAA, which disrupts vessel function and is associated with cerebral haemorrhage. Aβ has a relatively short half-life in the brain, ~4 h in older mice and ~6 h in humans. Major Aβ clearance pathways include receptor-mediated clearance by cells in brain parenchyma (by neurons and glia), along the interstitial fluid (ISF) drainage pathway, through the blood-brain barrier (BBB) and proteolytic degradation by endopeptidases. The comparative effects of apoE3 and apoE4 are indicated. In all major cellular Aβ clearance pathways, LRP1 is involved and is likely to clear Aβ either directly or when Aβ binds to its chaperones that are also LRP1 ligands (e.g. apoE, α2M). LDLR function in Aβ clearance is likely to involve Aβ-apoE complexes. VLDLR also has a role in the clearance of Aβ-apoE complexes at the BBB.
Publication
Apolipoprotein E and its receptors in Alzheimer’s disease: pathways, pathogenesis and therapy. () Guojun Bu. Nat Rev Neurosci. ;10(5):333-344. Figure: F4.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | CAA | CAA | ncbigene_synonym | TSHZ1 | 10194 |
| Homo sapiens | Primates | LRP1/LDLR | LRP1 | ncbigene_symbol | LRP1 | 4035 |
| Homo sapiens | Primates | LRP1/LDLR | LRP1 | ncbigene_synonym | C1D | 10438 |
| Homo sapiens | Primates | LRP1/LDLR | LDLR | ncbigene_symbol | LDLR | 3949 |
| Homo sapiens | Primates | AB | AB | ncbigene_synonym | APP | 351 |
| Homo sapiens | Primates | AB | AB | ncbigene_synonym | SUCLA2 | 8803 |
| Homo sapiens | Primates | Glia | GIIA | ncbigene_synonym | GANAB | 23193 |
| Homo sapiens | Primates | VLDLR | VLDLR | ncbigene_symbol | VLDLR | 7436 |
| Homo sapiens | Primates | byneprilysin,IDE,etc | IDE | ncbigene_symbol | IDE | 3416 |
| Word | Match | MeSH | Name | ChEBI |
|---|
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|